Skip to content

Kumar Neil

Reporting owner on Forms 3, 4 and 5, CIK 1742485.

Kumar Neil reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-20.

Issuers

IssuerRoles in the latest filingFilingsLast filed
BBIO · BridgeBio Pharma, Inc.CIK 1743881director, officer (Chief Executive Officer)22026-11-20

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
BBIO · BridgeBio Pharma, Inc.Common Stock2026-11-19S sold-8,500$78.3503477,186Form 4
BBIO · BridgeBio Pharma, Inc.Common Stock2026-11-19S sold-1,500$79.293475,686Form 4
BBIO · BridgeBio Pharma, Inc.Common Stock2026-11-18S sold-4,490$76.9916273,817Form 4
BBIO · BridgeBio Pharma, Inc.Common Stock2026-11-18S sold-30,490$77.8271243,327Form 4
BBIO · BridgeBio Pharma, Inc.Common Stock2026-11-18S sold-1,277$76.9915494,409Form 4
BBIO · BridgeBio Pharma, Inc.Common Stock2026-11-18S sold-8,723$77.8269485,686Form 4
BBIO · BridgeBio Pharma, Inc.Common Stock, holding 750,000Form 4
BBIO · BridgeBio Pharma, Inc.Common Stock, holding 3,568,447Form 4
BBIO · BridgeBio Pharma, Inc.Common Stock2026-11-16M exercised+33,544276,871Form 4
BBIO · BridgeBio Pharma, Inc.Common Stock2026-11-16M exercised+19,599296,470Form 4
BBIO · BridgeBio Pharma, Inc.Common Stock2026-11-16M exercised+11,554308,024Form 4
BBIO · BridgeBio Pharma, Inc.Common Stock2026-11-16M exercised+6,519314,543Form 4
BBIO · BridgeBio Pharma, Inc.Common Stock2026-11-16F withheld for tax-36,236$77.36278,307Form 4
BBIO · BridgeBio Pharma, Inc.Common Stock, holding 495,686Form 4
BBIO · BridgeBio Pharma, Inc.Common Stock, holding 750,000Form 4
BBIO · BridgeBio Pharma, Inc.Common Stock, holding 3,568,447Form 4
BBIO · BridgeBio Pharma, Inc.Restricted Stock Units, derivative2026-11-16M exercised-33,544$033,544Form 4
BBIO · BridgeBio Pharma, Inc.Restricted Stock Units, derivative2026-11-16M exercised-19,599$097,997Form 4
BBIO · BridgeBio Pharma, Inc.Restricted Stock Units, derivative2026-11-16M exercised-11,554$0103,984Form 4
BBIO · BridgeBio Pharma, Inc.Restricted Stock Units, derivative2026-11-16M exercised-6,519$084,755Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001743881-26-000045 BridgeBio Pharma, Inc.2026-11-20
Form 4 0001743881-26-000039 BridgeBio Pharma, Inc.2026-11-18